Gynoreva Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 4.10 M
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Gynoreva Lifesciences
Gynoreva Lifesciences Private Limited (GLPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 July 2022 (Two years and seven months 19 days old ). Its registered office is in Kozhikode, Kerala, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.10 M, as per Ministry of Corporate Affairs (MCA) records.
Elakkat Rajasekhar, Binesh Pandathel, Kanissery Kumar, and Three other members serve as directors at the Company.
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304KL2022PTC076640
- Company No.
076640
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Gynoreva Lifesciences?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Elakkat Rajasekhar  | Director | 07-Jul-2022 | Current |
| Binesh Pandathel | Director | 07-Jul-2022 | Current |
| Kanissery Kumar | Director | 07-Jul-2022 | Current |
| Anil | Director | 12-Aug-2022 | Current |
| Mattara Govindan | Director | 01-Jul-2023 | Current |
| Raveendran | Director | 01-Jul-2023 | Current |
Financial Performance of Gynoreva Lifesciences.
Enhance accessibility to Gynoreva Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gynoreva Lifesciences?
Unlock access to Gynoreva Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rossmed Lifesciences Private LimitedElakkat Rajasekhar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gynoreva Lifesciences?
Gynoreva Lifesciences has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gynoreva Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gynoreva Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.